Jiali Fu
Jinhua, 321000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
NDUFA10: An Emerging Oncogenic Driver of Metastasis in Lung Adenocarcinoma.
Journal: Current cancer drug targets
Published: October 04, 2025
TLyp-1-modified exosome-mediated delivery of circRAPGEF5 ASO inhibits lung adenocarcinoma metastasis via regulating the miR-570-3p/SPP1 axis.
Journal: Materials today. Bio
Published: April 24, 2025
A combined immune and exosome-related risk signature as prognostic biomakers in acute myeloid leukemia.
Journal: Hematology (Amsterdam, Netherlands)
Published: January 08, 2024
ADH1C Facilitates Cisplatin Resistance of Lung Adenocarcinoma Cells.
Journal: DNA and cell biology
Published: May 25, 2022
Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma.
Journal: Cancer cell international
Published: March 11, 2021
Low expression of PRKCDBP promoted cisplatin resistance in lung adenocarcinoma by DNMT1 and TNF‑α.
Journal: Oncology reports
Published: April 01, 2020
Analysis of lncRNA UCA1-related downstream pathways and molecules of cisplatin resistance in lung adenocarcinoma.
Journal: Journal of clinical laboratory analysis
Published: January 10, 2020
Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.
Journal: Journal of clinical laboratory analysis
Published: August 14, 2019
Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer.
Journal: Journal of clinical laboratory analysis
Published: April 26, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026